These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5372742)

  • 1. [Quantitative determination of the inhibitory effect of fibrinogen and its tryptic proteolysis products on fibrin polymerization].
    Mal'eva GV; Veretskaia TV
    Ukr Biokhim Zh; 1969; 41(6):691-7. PubMed ID: 5372742
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quantitative determination of protector activity of fibrinogen tryptic hydrolysates].
    Musialkivs'ka AO; Pozdniakova TM; Platonova TM; Khomenko VM
    Ukr Biokhim Zh; 1977; 49(4):118-23. PubMed ID: 19861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of tryptic hydrolysates of fibrin and fibrinogen on polymerization of monomer fibrin].
    Gavrish IN
    Ukr Biokhim Zh; 1970; 42(6):736-42. PubMed ID: 5513585
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen and fibrin protect fibroblast growth factor-2 from proteolytic degradation.
    Sahni A; Baker CA; Sporn LA; Francis CW
    Thromb Haemost; 2000 May; 83(5):736-41. PubMed ID: 10823272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physicochemical properties of a tryptic fibrinogen fragment--an inhibitor of fibrin polymerization].
    Varets'ka TV; Tsinkalovs'ka SM; Demchenko OP
    Ukr Biokhim Zh; 1972; 44(4):418-23. PubMed ID: 4655778
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolation and characterization of an high-molecular tryptic fibrinogen fragment--an inhibitor of fibrin polymerization].
    Belitser VO; Varets'ka TV; Tsinkalovs'ka SM; Pozdniakova TM; Tolstikh VM
    Ukr Biokhim Zh; 1972; 44(4):411-7. PubMed ID: 4655777
    [No Abstract]   [Full Text] [Related]  

  • 7. [EFFECT OF HIGHLY MOLECULAR FRACTIONS OF FIBRINOGEN TRYPSIN HYDROLYSATES ON THE POLYMERIZATION OF FIBRIN MONOMERS].
    MELNYCHUK IuP
    Ukr Biokhim Zh; 1963; 35():867-73. PubMed ID: 14186532
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 9. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M; Baba M; Morimoto K; Nakamikawa C
    J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incipient stage in thrombin-induced fibrin polymerization detected by FCS at the single molecule level.
    Bark N; Földes-Papp Z; Rigler R
    Biochem Biophys Res Commun; 1999 Jun; 260(1):35-41. PubMed ID: 10381340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of fibrinogen by the "fibrin-polymerization-time" test using Becton-Dickinson fibrometer].
    Donati MB; Vancoetsem T
    Pathol Biol (Paris); 1970; 18(11):697-8. PubMed ID: 4914157
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.
    Mosesson MW
    Blood Coagul Fibrinolysis; 1997 Jul; 8(5):257-67. PubMed ID: 9282789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
    Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
    Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen-fibrin degradation products.
    Kwaan HC
    Ann Clin Lab Sci; 1980; 10(3):234-7. PubMed ID: 7396389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization.
    Lu PD; Galanakis DK; Ghebrehiwet B; Peerschke EI
    Clin Immunol; 1999 Mar; 90(3):360-7. PubMed ID: 10075865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An analysis of a disorder in the fibrin-forming phase in virtually healthy middle-aged and elderly subjects by using the ancistron test].
    Platonova TN; Sushko OO; Lukinova NI; Solovĭov DA
    Fiziol Zh (1994); 1994; 40(3-4):63-70. PubMed ID: 7621957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of fibrin and fibrinogen in biological material.
    Haeberli A; Straub PW
    J Lab Clin Med; 1980 Aug; 96(2):258-66. PubMed ID: 6447180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of fibrin polymerization by fibrinogen proteolysis products.
    LATALLO ZS; FLETCHER AP; ALKJAERSIG N; SHERRY S
    Am J Physiol; 1962 Apr; 202():681-6. PubMed ID: 14462656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of inhibition of fibrin polymerization by fibrinogen and its active fragments].
    Belitser VA; Varetskaia TV; Kosterin SA
    Biokhimiia; 1980 Jan; 45(1):157-64. PubMed ID: 7213830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.